<?xml-model href='http://www.tei-c.org/release/xml/tei/custom/schema/relaxng/tei_all.rng' schematypens='http://relaxng.org/ns/structure/1.0'?><TEI xmlns="http://www.tei-c.org/ns/1.0">
	<teiHeader>
		<fileDesc>
			<titleStmt><title level='a'>Differences in cell shape, motility, and growth reflect chromosomal number variations that can be visualized with live-cell ChReporters</title></titleStmt>
			<publicationStmt>
				<publisher>PMC</publisher>
				<date>12/01/2023</date>
			</publicationStmt>
			<sourceDesc>
				<bibl> 
					<idno type="par_id">10503347</idno>
					<idno type="doi">10.1091/mbc.E23-06-0207</idno>
					<title level='j'>Molecular Biology of the Cell</title>
<idno>1059-1524</idno>
<biblScope unit="volume">34</biblScope>
<biblScope unit="issue">13</biblScope>					

					<author>Michael P. Tobin</author><author>Charlotte R. Pfeifer</author><author>Peter Kuangzheng Zhu</author><author>Brandon H. Hayes</author><author>Mai Wang</author><author>Manasvita Vashisth</author><author>Yuntao Xia</author><author>Steven H. Phan</author><author>Susanna A. Belt</author><author>Jerome Irianto</author><author>Dennis E. Discher</author><author>Valerie Marie Weaver</author>
				</bibl>
			</sourceDesc>
		</fileDesc>
		<profileDesc>
			<abstract><ab><![CDATA[<p>Chromosome numbers often change dynamically in tumors and cultured cells, which complicates therapy as well as understanding genotype-mechanotype relationships. Here we use a live-cell “ChReporter” method to identify cells with a single chromosomal loss in efforts to better understand differences in cell shape, motility, and growth. We focus on a standard cancer line and first show clonal populations that retain the ChReporter exhibit large differences in cell and nuclear morphology as well as motility. Phenotype metrics follow simple rules, including migratory persistence scaling with speed, and cytoskeletal differences are evident from drug responses, imaging, and single-cell RNA sequencing. However, mechanotype–genotype relationships between fluorescent ChReporter-positive clones proved complex and motivated comparisons of clones that differ only in loss or retention of a Chromosome-5 ChReporter. When lost, fluorescence-null cells show low expression of Chromosome-5 genes, including a key tumor suppressor APC that regulates microtubules and proliferation. Colonies are compact, nuclei are rounded, and cells proliferate more, with drug results implicating APC, and patient survival data indicating an association in multiple tumor-types. Visual identification of genotype with ChReporters can thus help clarify mechanotype and mechano-evolution.</p>]]></ab></abstract>
		</profileDesc>
	</teiHeader>
	<text><body xmlns="http://www.tei-c.org/ns/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>INTRODUCTION</head><p>The DNA sequence in a viable cell can change as a result of physical stressors that range from radiation to mechanical strain <ref type="bibr">(Hayes et al., 2023)</ref>. However, understanding any subsequent effects on a cell's phenotype -particularly its mechanotype -requires clear measures of the genotype of that individual living cell. In most cell lines and nearly all solid tumors, chromosome (Chr) losses and gains are typical and variable, altering the DNA from the 46 Chrs of a normal diploid cell (Table <ref type="table">1</ref>; Supplemental Figure <ref type="figure">S1A</ref>). This aneuploidy or copy number variation (CNV) is generally not static but ongoing <ref type="bibr">(Holland and Cleveland, 2009)</ref>, so that chromosomal differences between cells complicates single cell studies -including mechanobiology studies. Heterogeneity also frustrates cancer therapies such as targeted immunotherapies <ref type="bibr">(Davoli et al., 2013)</ref>. Loss of a Chr leads on average to proportional decreases in transcripts and proteins expressed from the affected Chr, and a gain has the opposite effect <ref type="bibr">(Pavelka et al., 2010;</ref><ref type="bibr">Torres et al., 2010;</ref><ref type="bibr">Stingele et al., 2012)</ref>. In yeast, disproportionate protein levels from aneuploid states alter the free versus bound levels in the normal stoichiometry of interacting proteins, affecting cell osmolarity and a cell's mechanical stress state <ref type="bibr">(Tsai et al., 2019)</ref>. Visualizing a living cell's genotype should thus help clarify mechanotypic variation.</p><p>Cancer geneticists often assume that loss (or gain) of a speci&#26112;&#26880;c Chr leads to a phenotype that mainly re&#26112;&#27648;ects the loss (or gain) of a "key" tumor suppressor gene (or cancer-driving oncogene) on that particular Chr <ref type="bibr">(Davoli et al., 2013)</ref>. Major de&#26112;&#26880;ciencies or defects in just a few such "key" genes seems suf&#26112;&#26880;cient to drive cancer and thus cannot be compensated by other genes <ref type="bibr">(Martincorena et al., 2017)</ref>. Of relevance to studies here is the loss of Chr-5 that decreases expression of all Chr-5 genes including the tumor suppressor Adenomatous polyposis coli (APC). We hypothesized that mechanotypic signatures of morphology, motility, and growth can relate to dominating differences in such a speci&#26112;&#26880;c Chr loss particularly when we visualize Chr differences between cells.</p><p>To address our hypothesis, we developed a general "ChReporter" method that allows us to see a speci&#26112;&#26880;c Chr loss in a living cell <ref type="bibr">(Hayes et al., 2023</ref>). As one particular example, the constitutive gene Lamin-B1 on Chr-5 was gene-edited as a monoallelic RFP or GFP fusion such that visible loss of the &#26112;&#27648;uorescent signal signi&#26112;&#26880;es loss of one copy of Chr-5. Detecting an increase in RFP signal can in principle be used to detect a Chr gain, but levels of Lamin-B1 happen to increase about two-fold from G1 to G2/M <ref type="bibr">(Hayes et al., 2023)</ref> whereas complete loss of signal is more obvious. In standard cultures of many cell lines, micronuclei are frequently seen and contain chromosomal DNA (Figure <ref type="figure">1A</ref> image, arrow) before loss or gain of a Chr in daughter cells of subsequent cell generations. Indeed, we have recently shown that rare RFP-negative cells emerging from pure RFP-positive cells (Figure <ref type="figure">1A</ref>) not only re&#26112;&#27648;ect loss of one allele of Chr-5 but also relate to abnormal mitosis on a range of substrate stiffnesses; these included collagen-coated soft gels on which cells exhibited more frequent mitotic errors and signi&#26112;&#26880;cantly higher Chr-5 loss than cells on plastic despite reduced proliferation <ref type="bibr">(Hayes et al., 2023)</ref>. Genetic methods applied to lysed or &#26112;&#26880;xed dead cells can con&#26112;&#26880;rm presumed changes in Chr number (e.g., Supplemental Figure <ref type="figure">S1B,</ref><ref type="figure">i</ref>), but such methods lack sensitivity to rare cells and lack spatiotemporal information. Simple visualization of CNV within live cells by ChReporters should thus accelerate insight and add con&#26112;&#26880;dence in studies despite ongoing instability and genetic diversi&#26112;&#26880;cation of the cells being studied (Supplemental Figure <ref type="figure">S1B</ref>, ii).</p><p>Our ChReporter method has been used to study multiple Chrs in normal diploid iPS cells and various cancer-cell lines <ref type="bibr">(Hayes et al., 2023)</ref>, including the A549 cells derived long ago from a patient with lung adenocarcinoma (LUAD; <ref type="bibr">Giard et al., 1973)</ref>. The A549 line is widely used to model normal lung epithelium <ref type="bibr">(Foster et al., 1998;</ref><ref type="bibr">Carterson et al., 2005)</ref>, but patients with such solid tumors are known to possess many CNV's even though loss or gain of whole Chr-5 in patients is rare (Supplemental Figure <ref type="figure">S2A</ref>). Although this observation suggests little advantage (i.e., neutral drift) for losing Chr-5 in terms of net growth and invasiveness of LUAD, rare Chr loss plus various epigenetic and mutational mechanisms can result in low APC levels that seem prognostic of poor survival in lung cancer (Supplemental Figure <ref type="figure">S2B</ref>, i) in addition to the well-appreciated effect in colorectal cancer even with immunotherapy <ref type="bibr">(He et al., 1998;</ref><ref type="bibr">Hankey et al., 2018)</ref>. We therefore sought to clarify genotypemechanotype relationships in vitro with A549 cells using our Chr-5 ChReporter and a progressive focus on the APC pathway.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RESULTS</head><p>To illustrate mechanotype-genotype complexity, we focus &#26112;&#26880;rst on four A549 clones that are all RFP-positive. Standard single cell expansion of clones P1-P4 began from a mixed population of RFPpositive cells and rare RFP-negative cells, with the latter being the source of N1-N4 clones studied later (Figure <ref type="figure">1A</ref>). While A549 cells undergo frequent changes to aneuploid states with high genetic variation (Table <ref type="table">1</ref>; Supplemental Figure <ref type="figure">S1, A</ref> and<ref type="figure">B</ref>), many isolated clones grow similarly with no major advantage from chromosomal selection (Supplemental Figure <ref type="figure">S1B</ref>, ii). Imaging P1 cells reveals a more rounded shape than P2-P4 clones, with morphological parameters for aspect ratio and circularity following a simple ellipse model prediction <ref type="bibr">(Figure 1B-i;</ref><ref type="bibr">Xia et al., 2018)</ref>. Depolymerization of MTs with Nocodazole drives cell rounding <ref type="bibr">(Chang et al., 2008)</ref>, and Nocodazole treatment of the highly elongated P3 cells phenocopied the rounded P1 cells <ref type="bibr">(Figure 1B,</ref><ref type="bibr">i,</ref><ref type="bibr">inset)</ref>. Depolymerization of F-actin with Latrunculin-A should also favor cell rounding <ref type="bibr">(Spector et al., 1989)</ref>, and although the effect is somewhat less than with Nocodazole, both drug results conform to the ellipse model. RFP-Lamin-B1 images also show more rounded P1 nuclei (Figure <ref type="figure">1B</ref>, ii). Nuclear shape trends track cell shapes but span a narrower range likely because nuclei are less deformable <ref type="bibr">(Buxboim et al., 2017)</ref>.</p><p>Defects in major cytoskeletal proteins seemed likely to underlie the distinctive morphology of P1 cells and suggested defects in other cytoskeletal-driven processes such as motility. Live imaging of sparsely plated clones was thus used to measure cell speed and persistence, showing P1 cells migrate far slower and with less persistence than P2-P4 cells (Figure <ref type="figure">1C</ref>). P4 cells are intermediate, consistent with an intermediate shape of the nucleus if not the cell.   Regardless, the &#8764;10-fold range in persistence helps convince that clone migration &#26112;&#26880;ts a power law:</p><p>Such a power law seems new for the &#26112;&#26880;eld, especially when comparing clones from the same cancer line of common genetic origin and similar epigenetics, which is relevant to tumor processes such as Epithelial-to-Mesenchymal transitions (EMT). The scaling exponent of about 2 also aligns with our analysis of past studies (Supplemental Figure <ref type="figure">S3A</ref>; Materials &amp; Methods). Furthermore, highly motile P3 cells treated with Nocodazole and Latrunculin-A phenocopied the low motility of P1 cells and scaled per Eq.1 (Figure <ref type="figure">1C</ref> inset). These mechanotype results suggest P1 cells are defective in MT, actin, and/or related cytoskeletal factors (Figure <ref type="figure">1D</ref>).</p><p>Given the overall hypothesis that differences in mechanotype properties relate to differences in speci&#26112;&#26880;c Chr losses or gains, we explored whether apparent cytoskeletal de&#26112;&#26880;ciencies in P1 cells result from gene expression decreases related to Chr loss. Single cell RNA-seq (scRNA-seq) was thus performed on the various clones, showing that major cytoskeletal genes such as beta tubulin (TUBB) and beta actin (ACTB) were highly downregulated in P1's whereas other related genes such as CDH2 show no change (Figure <ref type="figure">1E,</ref><ref type="figure">i</ref>). Average sc-RNAseq show reduced expression of P1's TUBB and ACTB even though overall RNA levels remain high (Figure <ref type="figure">1E</ref>, ii). Overall, cytoskeleton genes are among the most downregulated genes, con&#26112;&#26880;rming phenotypic observations of P1's compared with other P-clones (Figure <ref type="figure">1E</ref>, ii, inset). Further, immunostaining for MT's reveals MT organizing centers (MTOC) are suppressed in P1 versus P3 cells, providing insight into impaired MT functionality in P1 cells (Supplemental Figure <ref type="figure">S3B</ref>). Also, the essential role of MT's in mitosis is well-illustrated by Nocodazole effects <ref type="bibr">(De Brabander et al., 1976)</ref>; defective MT's in P1 cells should and do suppress proliferation (Supplemental Figure <ref type="figure">S3, C</ref> and<ref type="figure">D</ref>).</p><p>Upon deeper analysis of distinct P1 genes per Chr, several Chr's show large differences for P1 versus P2-4, with Chr-7 showing the biggest increases (Figure <ref type="figure">1E</ref>, iii). Importantly, Chr-5 shows no signi&#26112;&#26880;cant changes, consistent with our ChReporter method. However, other disparities (e.g., Chr's 1 and 17) confound deeper understanding of P1's speci&#26112;&#26880;c mechanotype, which illustrates the complexity of untangling genotype-mechanotype relationships. Potentially, livecell genetic approaches such as the ChReporter can begin to help, and comparing RFP-pos versus RFP-neg indeed shows a clearer genotype versus &#26112;&#27648;uorescence phenotype difference, consistent with the expected Chr-5 difference <ref type="bibr">(Figure 1E,</ref><ref type="bibr">iv)</ref>. This supports our visual ChReporter approach and motivates study of gene dosage effects between various P and N clones.</p><p>To pinpoint differences in genomic DNA rather than merely inferring differences from RNA, we analyzed Single Nucleotide Polymorphism (SNP)-array (SNPa) data for DNA isolated from each of the eight clones. Multiple Chr losses and gains are indeed clear relative to the P3 population (Figure <ref type="figure">2A</ref>), with Chr-5 lost in all N clones. N2-4 clones descend directly from P3 Chr-5 loss, whereas N1's seem to derive differently (Figure <ref type="figure">2A</ref>, bot) and indicate diverse processes of loss or gain from genome instability (e.g., Figure <ref type="figure">1A</ref>, inset). P1 shows Chr-7 gain, as inferred by scRNA-seq (Figure <ref type="figure">1E</ref>, i-iii) as made clear in standard UMAP projections (Figure <ref type="figure">2B</ref>). The P versus N difference arising from Chr-5 loss in the UMAP is also clear in a heatmap of each N when rescaled by the average of all P (Figure <ref type="figure">2C,</ref><ref type="figure">i</ref>).</p><p>Rather than comparing many different clones in terms of mechanotype that will emerge from the evolving genotype heterogeneity typical of cancer and cell lines (Supplemental Figure <ref type="figure">S1A</ref>), we instead focus on N3 and P3 clones with clear genetic differences only on Chr-5 (Figure <ref type="figure">2A</ref>). Genetic heterogeneity nonetheless emerges in these based on the observation that ChReporters can be lost under control conditions to a &#8764;0.5% level within days <ref type="bibr">(Hayes et al., 2023)</ref>; however such variance is more random and unbiased than the visible ChReporter difference that remains between these two populations after weeks of passaging (Supplemental Figure <ref type="figure">S3E</ref>). Furthermore, if any P3 cells lose this same Chr in the course of study (per Figure <ref type="figure">1A</ref>), then the cells and colonies become RFP-neg and can be ignored. In the future, use of multiple ChReporters can generalize the approach. Regardless, N3 cells show the expected gene dosage downregulation of most Chr-5 genes, including Lamin-B1, compared with P3 cells (Figure <ref type="figure">2</ref>, C ii, and D). Downregulation includes the APC tumor suppressor gene, which is notable because Chr loss is frequently associated by cancer geneticists to loss of such key tumor suppressor gene(s) that then drives the cancer <ref type="bibr">(Davoli et al., 2013)</ref>. Indeed, based on prior pancancer analyses, APC is by many orders of magnitude the highest ranked of just eight signi&#26112;&#26880;cant tumor suppressor genes on Chr-5 (Figure <ref type="figure">2E</ref>; Supplemental Table <ref type="table">S1</ref>). Reduced expression of the APC gene can affect its functionality, altering its ability to act as a WNT-signaling pathway antagonist, stabilize MTs, or permit cell motility <ref type="bibr">(Faux et al., 2004;</ref><ref type="bibr">Wen et al., 2004;</ref><ref type="bibr">Schneikert and Behrens, 2007)</ref>. Given observed Chr-5 copy number differences in living N3 and P3 cells, we hypothesize that mechanotype-related properties including aspects of morphology, motility, and proliferation can relate for N3 versus P3 to differences in APC levels despite the overall aneuploid background of the cells. Although variation of Chr-5 in lung cancer patients is relatively rare (Supplemental Figure <ref type="figure">S2</ref>), loss of a tumor suppressor can increase invasiveness and proliferation <ref type="bibr">(Davoli et al., 2013)</ref> and might also affect other hallmarks of cancer <ref type="bibr">(Hanahan and Weinberg, 2011)</ref>.</p><p>To begin to compare P3 and N3 mechanotypes, we imaged sparse cultures, which contained small proliferating clusters. Morphological differences were signi&#26112;&#26880;cant, with N3 colonies showing higher circularity or compactness versus P3 colonies (Figure <ref type="figure">3A</ref>). Cells that were isolated and well-separated from clusters displayed a typical migratory mechanotype but were several-fold less frequent for N3 cells, yielding an anticorrelation between cluster circularity and lone migratory cells <ref type="bibr">(Figure 3A,</ref><ref type="bibr">plot)</ref>. Because cell-cell adhesions as represented by junctional &#946;-catenin intensities were statistically the same for N3 and P3 (shown below), it is plausible that the migration is suppressed for N3 cells. These results thus raised the possibility of a "go or grow" competition <ref type="bibr">(Giese et al., 1996)</ref>, which proposes that cells which migrate fast and far do not divide very frequently, although the idea remains debated <ref type="bibr">(Zheng et al., 2009;</ref><ref type="bibr">Garay et al., 2013;</ref><ref type="bibr">Pfeifer et al., 2018)</ref>.</p><p>To examine migration coupled to proliferation, cells were densely seeded on Top of transwell &#26112;&#26880;lters with 8-&#181;m pores. These pores were used previously to reveal "go and grow" in 3D without the complications of nuclear rupture and DNA damage that are caused by smaller pores <ref type="bibr">(Irianto et al., 2017)</ref>. Given that APC is a tumor suppressor and the low frequency of cluster-isolated motile N3 cells (Figure <ref type="figure">3A</ref>), one prediction is that N3 cells migrate more slowly from the contact-inhibited transwell Top to the Bottom but reenter the cell cycle and grow more quickly on Bottom during the 1-d assay. Such offsetting processes can explain the statistically similar fractions of cells that have localized to Bottom for N3 and P3 (Figure <ref type="figure">3B,</ref><ref type="figure">i</ref>). Further, consistent with the prediction, N3 cells showed two-fold greater mitotic cell counts and EdU incorporation, indicating DNA replication and enhanced reentry into cell cycle following migration from the contact-inhibited Top (Figure <ref type="figure">3B</ref>, ii).  To more thoroughly characterize any proliferative advantage of N3 cells, we assayed EdU incorporation at varying cell densities in standard 2D cultures and quanti&#26112;&#26880;ed growth curves. N3 cells show increased replication at 24 h, with decreased replication at highest density conditions, consistent with contact-inhibition (Figure <ref type="figure">3C</ref>, i; <ref type="bibr">Abercrombie, 1979)</ref>. Cell counts also show that in both very sparse and denser 2D culture, N3 cells proliferate faster than P3 cells (Figure <ref type="figure">3C</ref>, ii). The &#8764;1.5 to two-fold higher N3 cell counts versus P3's after a few days re&#26112;&#27648;ects a faster doubling (27 vs. 30.5 h). Higher frequencies of mitotic missegregation events for N3 cells (Figure <ref type="figure">3D</ref>) is consistent with APC's role in MT stabilization and mitotic &#26112;&#26880;delity <ref type="bibr">(Wen et al., 2004;</ref><ref type="bibr">Caldwell and Kaplan, 2009)</ref>. Faster growth and genetic instability (upon Chr mis-segregation) are two key hallmarks of cancer and consistent with de&#26112;&#26880;cits in APC as a tumor suppressor.</p><p>To further explore the possible role of APC, we sought to disrupt APC function in P3 cells and phenocopy N3 cells (per Figure <ref type="figure">2C</ref>, ii). The drug CHIR-99021 causes protein-level inhibition of APC and two other proteins in a key &#946;-catenin destruction complex (Figure <ref type="figure">4A,</ref><ref type="figure">i</ref>). P3 cells treated with the CHIR antagonist indeed show increased &#946;-catenin content (&#8764;1.5-fold) when compared with nontreated cells (Figure <ref type="figure">4A</ref>, ii). CHIR-treated P3 cells phenocopy the proliferative advantage of N3 cells relative to P3 controls while also generating distinctly larger and more rounded nuclear morphologies (Figure <ref type="figure">4B</ref>). In general, drugs that rescue the decreased activity of Tumor Suppressor genes such as APC (in N3 cells for example) could be clinically useful but do not exist (Supplemental Table <ref type="table">S1</ref>). APC knockdown in various cancer lines nonetheless con&#26112;&#26880;rm &#26112;&#26880;ndings here for N3 cells relative to P3 cells, including mitotic aberrations (U2OS cells), more cells in S &amp; G2M phases (MDA-MB-231 cells), and increased overall proliferation (pancreatic and lung cancer lines) <ref type="bibr">(Dikovskaya et al., 2007;</ref><ref type="bibr">Lin et al., 2017;</ref><ref type="bibr">Cole et al., 2019;</ref><ref type="bibr">Astarita et al., 2021)</ref>. Mechanisms seem to involve upregulation of cyclin D1 and cMyc <ref type="bibr">(Heinen et al., 2002)</ref>, but more rounded nuclei in APC-de&#26112;&#26880;cient N3 and treated P3 cells further suggest a perturbation of polarizing cytoskeletal components that could re&#26112;&#27648;ect diminished interaction between APC and MTs <ref type="bibr">(Hernandez and Tirnauer, 2010)</ref>. Thus, despite the mechano-complexity of aneuploidy <ref type="bibr">(Tsai et al., 2019)</ref>, a summary heat map highlights replicative and morphological differences reasonably associated with decreased APC (Figure <ref type="figure">4C</ref>).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>CONCLUSIONS</head><p>Evolution involves two processes: the &#26112;&#26880;rst is genetic variation, and the second is selection for survival of the &#26112;&#26880;ttest. In seeking to characterize and understand the latter in terms of mechanotype differences between genetically distinct clones, we show that a difference in Chr number between live cells is enabled by a general method of ChReporter visualization that provides con&#26112;&#26880;dence in genotype differences -despite evident and ongoing diversi&#26112;&#26880;cation.</p><p>The two parts of the study here compare different aneuploid A549 cells to illustrate &#26112;&#26880;rst a confounding complexity of genotype with major mechanotypical differences (Figure <ref type="figure">1</ref>) and then a reasonably clear genotype-mechanotype relationship (Figures <ref type="figure">2</ref><ref type="figure">3</ref><ref type="figure">4</ref>). While phenotypic changes might arise from a number of diverse factors that range from intrinsically genetic to environmentallydriven epigenetic, the molecular mechanisms proposed by our genotype-mechanotype relationship is supported by drug results that implicate the main tumor suppressor gene APC on the relevant Chr. Part of Chr-5 with the APC gene is lost in a small fraction of lung cancer patients who show worse survival (Supplemental Figure <ref type="figure">S2</ref>). The latter applies to colorectal cancer <ref type="bibr">(He et al., 1998;</ref><ref type="bibr">Zhang and Shay, 2017)</ref> but also other cancers (Supplemental Figure <ref type="figure">S2B</ref>, ii), consistent with a broader than appreciated role for APC as a tumor suppressor. This could be important because some types of aneuploidy, notably Chr-1 gain, drives higher LUAD patient response rates to immunotherapy <ref type="bibr">(Ng et al., 2023)</ref>. Regardless, the ChReporter approach seems promising for genotype-mechanotype studies of cancers, including those foundational to genetic mechano-evolution.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MATERIALS AND METHODS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cell lines and tissue culture</head><p>The original A549 RFP-LMNB1 cell line was engineered by Sigma-Aldrich (Sigma, Catalog no. #CLL1149). A549 cells were cultured in Ham's F-12 media (Life Technologies #11765047) and supplemented with 10% fetal bovine serum (MilliporeSigma, Catalog no. #F2442) and 1% penicillin-streptomycin (Life Technologies, Catalog no. #15140122). All cells were passaged every 2-3 d using 0.05% Trypsin/ ethylenediaminetetraacetic acid (Life Technologies, Catalog no. #25300054). All cell lines were incubated at 37&#176;C with 5% CO 2 .</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cell treatments</head><p>The following chemical treatments were used: nocodazole (Milli-poreSigma, Catalog no. #M1404), Latrunculin-A (MilliporeSigma, Catalog no #L5163), and GSK-3 inhibitor CHIR-99021 (Millipore-Sigma, Catalog no. #SML1046).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Immunofluorescence and imaging</head><p>Cells were &#26112;&#26880;xed in 4% formaldehyde (Thermo Fisher Scienti&#26112;&#26880;c, Catalog no. #28908) for 15 min, followed by permeabilization by 0.5% Triton-X (MilliporeSigma, Catalog no. #112298) for 15 min, and blocked with 5% bovine serum albumin (BSA; MilliporeSigma, Catalog no. #A7906) for 30 min. Nuclei were stained with 8&#956;M Hoechst 33342 (Thermo Fisher, #Catalog no. 62249) for 15 min. When mounting is involved, Prolong Gold antifade reagent was used (Invitrogen, Catalog no. #P36930). Epi&#26112;&#27648;uorescence imaging was performed using an Olympus IX71 with a digital camera (Photometrics) and either a 10&#215;/0.2 NA or 40&#215;/0.6 NA objective. For certain samples, confocal imaging was performed on a Leica TCS SP8 system with a 63&#215;/1.4 NA oil-immersion. Live imaging was performed on an EVOS FL Auto Imaging System with 10 &#215; or 20&#215;/0.6 NA object in normal culture conditions (37&#176;C and 5% CO 2 ; complete culture medium as speci&#26112;&#26880;ed above).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Live-cell imaging of cell motility</head><p>All studied A549 RFP-LMNB1 clones were plated 24 h before assay at a density of 4000 cells per well in a 12-well plate (Corning). Liveimaging was done using an EVOS FL Auto Imaging System with a 10&#215; objective with cells under normal culture conditions (37&#176;C and 5% CO 2 ; complete culture medium). One image was taken every hour for a total of 6 h. Migration paths of cells were traced with MATLAB, with the original location of cells labeled as the origin coordinate (x, y) = (0, 0). Speed was calculated using the ImageJ Plugin MTrackJ: for each cell, its x, y coordinates were recorded by MTrackJ from t = 0 to 6 h at 1-h intervals. The mean speed v for each cell over the 6-h span was calculated as the sum of all distances traveled divided by total time span. Mathematically, the expression is: v x x y y / 6</p><p>, where i denotes the time step for each cell imaged. Migratory persistence P for each clone or condition was calculated as</p><p>, where D is the diffusion coef&#26112;&#26880;cient, given by the slope of the mean squared displacement (for all cells of the given clone or condition) versus time t.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>EdU labeling and staining</head><p>10 &#181;M 5-ethynyl-2&#8242;-deoxyuridine (EdU; Abcam, Catalog no. #ab146186) was added to 2D culture or both sides of a pore &#26112;&#26880;lter 1 h before &#26112;&#26880;xation and permeabilization. After permeabilization, EdU-labeled cells were stained as follows by a click chemistry reaction: cells were incubated in 100 mM Tris (pH 8.5, Fisher Scienti&#26112;&#26880;c, 77-86-1), 4 mM CuSO 4 (MilliporeSigma, Catalog no. #C1297), 5 &#181;M sulfonated Cy5 azide (Click Chemistry Tools, Catalog no. 1509), and 50 mM ascorbic acid (MilliporeSigma, Catalog no. #A8960) for 30 min, and then washed 3&#215; with 0.1% BSA in phosphate-buffered saline.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Transwell migration</head><p>Cells were seeded at 4.5 &#215; 10 5 cells/cm 2 on top of 8-&#181;m pore &#26112;&#26880;lters, mounted in 24-well polycarbonate inserts (Corning). For 24 h, cells were allowed to migrate through the pores in normal culture conditions; during the last 1 h, EdU was added to the culture medium above and below each pore membrane. After the 24-h migration period, cells attached to the top and bottom of the membranes were &#26112;&#26880;xed, permeabilized, and stained as described above. All membranes were mounted between glass coverslips using ProLong Gold antifade mountant. All &#26112;&#26880;xation and staining steps were carried out at room temperature.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cell growth curves</head><p>At t = 0 h, RFP-positive and RFP-negative clones (P3 and N3, respectively) were each seeded in a 24-well plate at extremely low density (2.6 &#215; 10 2 cells/cm 2 ). Starting at t = 24 h, every 24 h for 96 h total, tile scanning was used to image one-half of each sample well. Imaging was performed on an Olympus IX71--with a 10&#215;/0.2 NA objectiveand a digital EMCCD camera. For every timepoint under sparse conditions, the number of cells in each half-well was manually counted from the images, and then multiplied by two to get the total number of cells per well, or the total population of each experimental condition. For denser plating experiments, duplicate wells were trypsinized and counted. Fits to exponential growth y = ae kx exclude t = 0 h, where cell density is merely an estimate, and &#26112;&#26880;ts to y = 10 mx + b exclude t = 0 h.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Identifying and analyzing cell clusters</head><p>Cell cluster analysis was performed using growth curve images of P3 and N3 cells at t = 72 h. From both the P3 and the N3 image set, clusters comprising 10 or more cells were identi&#26112;&#26880;ed by eye, and 15 such clusters were randomly selected for analysis. Cells were classi-&#26112;&#26880;ed as belonging to a cluster if they were part of-or within &#8764;20 &#181;m of-a conspicuous locally dense cell aggregate. All other cells were considered isolated. Clusters were manually outlined in ImageJ <ref type="bibr">(Schneider et al., 2012)</ref> to measure cluster perimeter P and area A; the latter was divided by the number of cells in the cluster to obtain area-per-cell. By contrast, average cell area was obtained by manual segmentation of individual cells. Compactness C of each cluster was calculated as C = 4&#960;A/P 2 , as described in <ref type="bibr">(Li et al., 2013)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>scRNA-seq and analysis</head><p>RNA libraries were constructed using the Chromium Single Cell Gene Expression kit (v3.1, single index, Catalog no. #PN-1000128; #PN-1000127; #PN-1000213) from 10&#215; Genomics per the manufacturer's instructions. Libraries were submitted to the University of Pennsylvania's Next Generation Sequencing Core for sequencing using NovaSeq 6000 (100 cycles) from Illumina. CellRanger (version 5.0.1) was used to analyze raw base call (BCL) to generate FASTQ &#26112;&#26880;les and the "count" command was used to generate raw count matrices aligned to GRCh38 provided by 10&#215; genomics. The data generated was imported as a Seurat object (4.0.0) for future downstream analysis <ref type="bibr">(Stuart et al., 2019;</ref><ref type="bibr">Hao et al., 2021)</ref>. Cells were &#26112;&#26880;ltered to express between 500 and 6000 genes to eliminate low quality cells and had less than 10% mitochondrial RNA. Differential gene expression analysis was performed using the "FindAllMarkers" function and genes with nonzero expression in at least 25% of the cells in both cohorts were kept. The UMAP was created using the &#26112;&#26880;rst 12 principle components based on the Elbow Plot. The function "AverageExpression" was used to evaluate average gene expression in each cohort and when necessary, data was normalized using the "LogNormalize" method. The biomaRT library and useEnsembl were used to identify Chr number and hgnc symbol for the genes. DAVID <ref type="bibr">(Sherman et al., 2022)</ref> was used for gene annotation analysis. All sc-mRNAseq analysis was done in R version 4.0.4.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Identification of CNV from single-cell RNAseq data</head><p>inferCNV <ref type="bibr">(Tickle, 2019)</ref> was used to tag the sc-mRNAseq from A549 cells with labels of clone (P1, P2, P3, P4, N3) with annotation input being given for RFP-Pos vs RFP-Neg cells.</p><p>Single Cell DNA-seq CNV analysis DNA library was constructed using Chromium Single Cell DNA Reagent kits (PN-1000041, PN-1000057, PN-120262, PN-1000032, PN-1000036) from 10&#215; Genomics (Pleasanton, CA) per the manufacturer's instructions. Library prepared was processed at the Next Generation Sequencing Core at the University of Pennsylvania (12-160, Translational Research Center, University of Pennsylvania) using NovaSeq 6000, 200 cycles (Illumina, San Diego, CA). For each sample, the copy number data was generated using Cell Ranger DNA pipeline (10&#215; Genomics) and then exported to R to generate the copy number heatmap using "ComplexHeatmap" (2.11.1).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>TCGA LUAD patient CNV profiling and survival analyses</head><p>CNV (masked cnv) was downloaded from UCSC Xena website (<ref type="url">https://xenabrowser.net/datapages/</ref>; <ref type="bibr">Goldman et al., 2020)</ref>. The CNV pro&#26112;&#26880;le heatmap was then generated using R package "Com-plexHeatmap" (v2.11.1). Patient survival curves derive from the human protein atlas, speci&#26112;&#26880;cally using the 'pathology' tab (<ref type="url">https:// www.proteinatlas.org/</ref>; <ref type="bibr">Uhlen et al., 2015)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>TCGA and CCLE analysis</head><p>For TCGA analysis, CNV (masked cnv) and phenotype data was downloaded from UCSC Xena website (<ref type="url">https://xenabrowser.net/</ref> datapages/; <ref type="bibr">Goldman et al., 2020)</ref>. Aneuploidy level from TCGA was assessed using a recently published dataset <ref type="bibr">(Knijnenburg et al., 2018)</ref>. For CCLE, CNV (CCLE_segment_cn) and phenotype data was downloaded from the DepMap portal (<ref type="url">https://depmap.org/</ref> portal/download/all/). CCLE copy number was reported as the ratio between the copy number and the basal reference of the sample, a region with two copies of Chrs will have a ratio of one. The aneuploidy level was obtained by summing |reported ratio -1| &#215; segment length of the reported ratio within each sample. All aneuploidy levels were normalized to the maximum.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Reporter validation via single-nucleotide polymorphism arrays and analysis</head><p>Genomic DNA was isolated from a minimum of 3.0 &#215; 10 5 cells with the Blood &amp; Cell Culture DNA Mini Kit (Qiagen, Catalog no. #13323) per the manufacturer's instructions. In the event that cells were very rare (such as reporter-negative cells), genomic DNA was ampli&#26112;&#26880;ed postextraction using the Illustra Single Cell GenomiPhi DNA Ampli-&#26112;&#26880;cation Kit (GE Healthcare Biosciences, Catalog no. #29108107) following the manufacturer's instructions. All DNA samples were sent to The Center for Applied Genomics Core in The Children's Hospital of Philadelphia, PA, for SNP array HumanOmniExpress-24 Bead-Chip Kit (Illumina). For this array, &gt;700,000 probes have an average inter-probe distance of &#8764;4 kb along the entire genome. For each sample, the Genomics Core provided the data in the form of Ge-nomeStudio &#26112;&#26880;les (Illumina). Chr copy number and loss of heterozygosity (LOH) regions were analyzed in GenomeStudio by using the cnvPartition plug-in (Illumina). Regions with one Chr copy number are not associated with LOH by Illumina's algorithm. Hence, regions with one Chr copy number as given by the GenomeStudio are added to the LOH region lists. SNP array experiments also provide genotype data, which was used to give Single Nucleotide Variation (SNV) data. To increase the con&#26112;&#26880;dence of LOH data given by the GenomeStudio, the changes in LOH of each Chr from each sample were cross referenced to their corresponding SNV data. After extracting data from GenomeStudio, all data analysis was done in MATLAB.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Karyotyping</head><p>Cells used for karyotyping were plated in T25 &#26112;&#27648;asks (Corning), cultured for 2-3 d to reach &#8764;50% con&#26112;&#27648;uency. The media was then discarded and replaced with fresh media to &#26112;&#26880;ll the entire &#26112;&#27648;ask with a closed lid, after which the &#26112;&#27648;ask was wrapped with para&#26112;&#26880;lm. The samples were then sent to Cell Characterization Services for metaphase-spread karyotyping.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Scaling of migratory persistence and speed</head><p>From the two-phase model of cell migration developed by <ref type="bibr">Li and Sun (2018)</ref>, we have the following Equation (1) for the velocity v 0 of a cell migrating on a 2D substrate:</p><p>where L and w the length and width of the cell, respectively; &#951; is the coef&#26112;&#26880;cient of drag due to focal adhesions; J actin is the rate of F-actin polymerization; f ext f r / is the external force per unit area at the front/rear of the cell; &#920; is the average volume fraction of the actin network; and &#958; is the coef&#26112;&#26880;cient of friction of the substrate. In the limit of large &#951; -as can be assumed for cells cultured on rigid plastic <ref type="bibr">(Pelham and Wang, 1997)</ref> and especially for cells with disrupted MTs <ref type="bibr">(Bershadsky et al., 1996;</ref><ref type="bibr">Enomoto, 1996)</ref> -Eq. (1) reduces to Equation (2):</p><p>That is, cell velocity depends on actin polymerization rate. In turn, actin polymerization rate depends on MT activity. In two separate experiments, Waterman and coworkers measured MT growth and level of active Rac1 for 30-60 min after nocodazole washout <ref type="bibr">(Waterman-Storer et al., 1999)</ref>. By matching time points between these two experiments, we plotted Rac1 as a function of MT growth (Supplemental Figure <ref type="figure">S3A</ref>, i). To note, MT growth at t = 30 min was not published by <ref type="bibr">Waterman et al. (1999)</ref>. We estimated this value by &#26112;&#26880;tting power laws to the measurements of MT growth at t = 2 min and t = 20 min (with 10% of t = 2 min growth assumed at t = 0), and then extrapolating to longer times. This gives two scaling exponents-0.38 and 0.60-for the two metrics of MT growth used by <ref type="bibr">Waterman et al. (1999)</ref>; thus, we estimate that active Rac1 level goes like MT growth to the power of 1/2, or [GTP-Rac1] &#8764;[MT] 0.5 . Assuming a linear relationship between [GTP-Rac1] and F-actin polymerization rate, as in the mechanochemical coupling model of cell polarization developed by <ref type="bibr">Copos and Mogilner (2020)</ref>, we obtain Equation (3):</p><p>MTs are critical for maintaining front-rear cell polarization and are therefore expected to promote migratory persistence P. <ref type="bibr">Pegtel and colleagues (2007)</ref> measured the persistence of migrating cells treated with different doses of nocodazole. In replotting their data, we &#26112;&#26880;nd that persistence is inversely proportional to nocodazole concentration <ref type="bibr">(Supplemental Figure S3A,</ref><ref type="bibr">ii)</ref>. Across the range of nocodazole concentrations in Supplemental Figure <ref type="figure">S3A</ref>, iii), the relationship between MT activity and [noco.] is assumed to be in a linear regime. This assumption is based on an experiment performed by <ref type="bibr">Vasquez and coworkers (1997)</ref>, whereby two different cell types were treated with different doses of nocodazole, and then measured for such parameters as MT elongation velocity, catastrophe frequency, and dynamicity. MT dynamicity, an estimate of the number of tubulin subunits exchanged at MT ends, is plotted in Supplemental Figure <ref type="figure">S3A</ref>, iii) as a function of [noco.]. Because P is inversely proportional to nocodazole concentration, which varies linearly with [MT], it follows that P &#8764; [MT]. Finally, because v 0 &#8764; [MT] 0.5 and P &#8764; [MT], we predict that P &#8764; v 0 2 , which is indeed the scaling relationship observed between migratory persistence and speed.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistics and reproducibility</head><p>The statistical methods for each experiment are included in the corresponding Figure legends. Signi&#26112;&#26880;cance was determined by an unpaired t test unless otherwise noted. All statistical analyses were done using Python, R (version 4.0.4), and GraphPad Prism 9.0.</p></div></body>
		</text>
</TEI>
